Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 250

1.

A novel confidence interval for a single proportion in the presence of clustered binary outcome data.

Short MI, Cabral HJ, Weinberg JM, LaValley MP, Massaro JM.

Stat Methods Med Res. 2019 Jan 23:962280218823231. doi: 10.1177/0962280218823231. [Epub ahead of print]

PMID:
30672389
2.

Blood kidney injury molecule-1 predicts short and longer term kidney outcomes in patients undergoing diagnostic coronary and/or peripheral angiography-Results from the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) study.

Ibrahim NE, McCarthy CP, Shrestha S, Lyass A, Li Y, Gaggin HK, Simon ML, Massaro JM, D'Agostino RB Sr, Garasic JM, van Kimmenade RR, Januzzi JL Jr.

Am Heart J. 2019 Mar;209:36-46. doi: 10.1016/j.ahj.2018.12.001. Epub 2018 Dec 7.

PMID:
30641399
3.

Liver Fat Is Associated With Markers of Inflammation and Oxidative Stress in Analysis of Data From the Framingham Heart Study.

Fricker ZP, Pedley A, Massaro JM, Vasan RS, Hoffmann U, Benjamin EJ, Long MT.

Clin Gastroenterol Hepatol. 2018 Nov 23. pii: S1542-3565(18)31280-1. doi: 10.1016/j.cgh.2018.11.037. [Epub ahead of print]

PMID:
30476583
4.

Estimated Life Expectancy Without Recurrent Cardiovascular Events in Patients With Vascular Disease: The SMART-REACH Model.

Kaasenbrood L, Bhatt DL, Dorresteijn JAN, Wilson PWF, D'Agostino RB Sr, Massaro JM, van der Graaf Y, Cramer MJM, Kappelle LJ, de Borst GJ, Steg PG, Visseren FLJ.

J Am Heart Assoc. 2018 Aug 21;7(16):e009217. doi: 10.1161/JAHA.118.009217.

5.

Benefit and Risk of Prolonged DAPT After Coronary Stenting in Women.

Berry NC, Kereiakes DJ, Yeh RW, Steg PG, Cutlip DE, Jacobs AK, Abbott JD, Hsieh WH, Massaro JM, Mauri L; DAPT Study Investigators.

Circ Cardiovasc Interv. 2018 Aug;11(8):e005308. doi: 10.1161/CIRCINTERVENTIONS.117.005308.

PMID:
30354781
6.

Astronaut Cardiovascular Health and Risk Modification (Astro-CHARM) Coronary Calcium Atherosclerotic Cardiovascular Disease Risk Calculator.

Khera A, Budoff MJ, O'Donnell CJ, Ayers CA, Locke J, de Lemos JA, Massaro JM, McClelland RL, Taylor A, Levine BD.

Circulation. 2018 Oct 23;138(17):1819-1827. doi: 10.1161/CIRCULATIONAHA.118.033505.

7.

Subgroup Analysis Comparing Ultrathin, Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin, Durable Polymer Everolimus-Eluting Stents in Acute Coronary Syndrome Patients.

Roguin A, Kandzari DE, Marcusohn E, Koolen JJ, Doros G, Massaro JM, Garcia-Garcia HM, Bennett J, Gharib EG, Cutlip DE, Waksman R.

Circ Cardiovasc Interv. 2018 Oct;11(10):e007331. doi: 10.1161/CIRCINTERVENTIONS.118.007331.

PMID:
30354631
8.

Endothelin-1 Measurement in Patients Undergoing Diagnostic Coronary Angiography-Results from the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) Study.

Ibrahim NE, Gupta R, Lyass A, Li Y, Shrestha S, McCarthy CP, Gaggin HK, van Kimmenade RRJ, Massaro JM, D'Agostino RB Sr, Januzzi JL Jr.

Clin Chem. 2018 Nov;64(11):1617-1625. doi: 10.1373/clinchem.2017.286385. Epub 2018 Sep 13.

PMID:
30213784
9.

Parental non-alcoholic fatty liver disease increases risk of non-alcoholic fatty liver disease in offspring.

Long MT, Gurary EB, Massaro JM, Ma J, Hoffmann U, Chung RT, Benjamin EJ, Loomba R.

Liver Int. 2018 Sep 4. doi: 10.1111/liv.13956. [Epub ahead of print]

PMID:
30179294
10.

One-Year Safety and Clinical Outcomes of a Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction in the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (REDUCE LAP-HF I) Trial: A Randomized Clinical Trial.

Shah SJ, Feldman T, Ricciardi MJ, Kahwash R, Lilly S, Litwin S, Nielsen CD, van der Harst P, Hoendermis E, Penicka M, Bartunek J, Fail PS, Kaye DM, Walton A, Petrie MC, Walker N, Basuray A, Yakubov S, Hummel SL, Chetcuti S, Forde-McLean R, Herrmann HC, Burkhoff D, Massaro JM, Cleland JGF, Mauri L.

JAMA Cardiol. 2018 Oct 1;3(10):968-977. doi: 10.1001/jamacardio.2018.2936.

PMID:
30167646
11.

Protein Biomarkers of Cardiovascular Disease and Mortality in the Community.

Ho JE, Lyass A, Courchesne P, Chen G, Liu C, Yin X, Hwang SJ, Massaro JM, Larson MG, Levy D.

J Am Heart Assoc. 2018 Jul 13;7(14). pii: e008108. doi: 10.1161/JAHA.117.008108.

12.

Aortic Arch Width and Cardiovascular Disease in Men and Women in the Community.

Chuang ML, Gona PN, Qazi S, Musgrave RM, Fox CS, Massaro JM, Hoffmann U, O'Donnell CJ.

J Am Heart Assoc. 2018 Jun 16;7(12). pii: e008057. doi: 10.1161/JAHA.117.008057.

13.

Observational and Genetic Associations of Resting Heart Rate With Aortic Valve Calcium.

Whelton SP, Mauer AC, Pencina KM, Massaro JM, D'Agostino RB, Fox CS, Hoffmann U, Michos ED, Peloso GM, Dufresne L, Engert JC, Kathiresan S, Budoff M, Post WS, Thanassoulis G, O'Donnell CJ.

Am J Cardiol. 2018 May 15;121(10):1246-1252. doi: 10.1016/j.amjcard.2018.01.048. Epub 2018 Feb 13.

PMID:
29656781
14.

Total cardiovascular events analysis of the EXAMINE trial in patients with type 2 diabetes and recent acute coronary syndrome.

Cavender MA, White WB, Liu Y, Massaro JM, Bergenstal RM, Mehta CR, Zannad F, Heller S, Cushman WC, Cannon CP.

Clin Cardiol. 2018 Aug;41(8):1022-1027. doi: 10.1002/clc.22960. Epub 2018 Aug 16.

15.

Single-Molecule Counting of High-Sensitivity Troponin I in Patients Referred for Diagnostic Angiography: Results From the CASABLANCA (Catheter Sampled Blood Archive in Cardiovascular Diseases) Study.

McCarthy CP, Ibrahim NE, Lyass A, Li Y, Gaggin HK, Simon ML, Mukai R, Gandhi P, Kelly N, Motiwala SR, van Kimmenade RRJ, Massaro JM, D'Agostino RB Sr, Januzzi JL Jr.

J Am Heart Assoc. 2018 Mar 8;7(6). pii: e007975. doi: 10.1161/JAHA.117.007975.

16.

Visceral and Intrahepatic Fat Are Associated with Cardiometabolic Risk Factors Above Other Ectopic Fat Depots: The Framingham Heart Study.

Lee JJ, Pedley A, Hoffmann U, Massaro JM, Levy D, Long MT.

Am J Med. 2018 Jun;131(6):684-692.e12. doi: 10.1016/j.amjmed.2018.02.002. Epub 2018 Mar 5.

PMID:
29518370
17.

Cardiovascular Risk Prediction Functions Underestimate Risk in HIV Infection.

Triant VA, Perez J, Regan S, Massaro JM, Meigs JB, Grinspoon SK, D'Agostino RB Sr.

Circulation. 2018 May 22;137(21):2203-2214. doi: 10.1161/CIRCULATIONAHA.117.028975. Epub 2018 Feb 14.

PMID:
29444987
18.

Predicting new-onset HF in patients undergoing coronary or peripheral angiography: results from the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) study.

Ibrahim NE, Lyass A, Gaggin HK, Liu Y, van Kimmenade RRJ, Motiwala SR, Kelly NP, Gandhi PU, Simon ML, Belcher AM, Harisiades JE, Massaro JM, D'Agostino RB, Januzzi JL Jr.

ESC Heart Fail. 2018 Jun;5(3):240-248. doi: 10.1002/ehf2.12268. Epub 2018 Feb 9.

19.

A simple clinical model predicts incident hepatic steatosis in a community-based cohort: The Framingham Heart Study.

Long MT, Pedley A, Massaro JM, Hoffmann U, Ma J, Loomba R, Chung RT, Benjamin EJ.

Liver Int. 2018 Aug;38(8):1495-1503. doi: 10.1111/liv.13709. Epub 2018 Mar 12.

PMID:
29377504
20.

Survey of plasma proteins in children with progeria pre-therapy and on-therapy with lonafarnib.

Gordon LB, Campbell SE, Massaro JM, D'Agostino RB Sr, Kleinman ME, Kieran MW, Moses MA.

Pediatr Res. 2018 May;83(5):982-992. doi: 10.1038/pr.2018.9. Epub 2018 Feb 28.

PMID:
29342131
21.

Maintenance of Ideal Cardiovascular Health and Coronary Artery Calcium Progression in Low-Risk Men and Women in the Framingham Heart Study.

Hwang SJ, Onuma O, Massaro JM, Zhang X, Fu YP, Hoffmann U, Fox CS, O'Donnell CJ.

Circ Cardiovasc Imaging. 2018 Jan;11(1):e006209. doi: 10.1161/CIRCIMAGING.117.006209.

22.

Increased Aortic Diameters on Multidetector Computed Tomographic Scan Are Independent Predictors of Incident Adverse Cardiovascular Events: The Framingham Heart Study.

Qazi S, Massaro JM, Chuang ML, D'Agostino RB Sr, Hoffmann U, O'Donnell CJ.

Circ Cardiovasc Imaging. 2017 Dec;10(12). pii: e006776. doi: 10.1161/CIRCIMAGING.117.006776.

23.

Longitudinal Associations of Pericardial and Intrathoracic Fat With Progression of Coronary Artery Calcium (from the Framingham Heart Study).

Lee JJ, Pedley A, Hoffmann U, Massaro JM, O'Donnell CJ, Benjamin EJ, Long MT.

Am J Cardiol. 2018 Jan 15;121(2):162-167. doi: 10.1016/j.amjcard.2017.10.006. Epub 2017 Oct 19.

24.

Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial.

Feldman T, Mauri L, Kahwash R, Litwin S, Ricciardi MJ, van der Harst P, Penicka M, Fail PS, Kaye DM, Petrie MC, Basuray A, Hummel SL, Forde-McLean R, Nielsen CD, Lilly S, Massaro JM, Burkhoff D, Shah SJ; REDUCE LAP-HF I Investigators and Study Coordinators.

Circulation. 2018 Jan 23;137(4):364-375. doi: 10.1161/CIRCULATIONAHA.117.032094. Epub 2017 Nov 15.

PMID:
29142012
25.

Rationale of a novel study design for the BIOFLOW V study, a prospective, randomized multicenter study to assess the safety and efficacy of the Orsiro sirolimus-eluting coronary stent system using a Bayesian approach.

Doros G, Massaro JM, Kandzari DE, Waksman R, Koolen JJ, Cutlip DE, Mauri L.

Am Heart J. 2017 Nov;193:35-45. doi: 10.1016/j.ahj.2017.08.001. Epub 2017 Aug 5.

PMID:
29129253
26.

Lesion Complexity and Outcomes of Extended Dual Antiplatelet Therapy After Percutaneous Coronary Intervention.

Yeh RW, Kereiakes DJ, Steg PG, Cutlip DE, Croce KJ, Massaro JM, Mauri L; DAPT Study Investigators.

J Am Coll Cardiol. 2017 Oct 31;70(18):2213-2223. doi: 10.1016/j.jacc.2017.09.011.

27.

Age and Graphomotor Decision Making Assessed with the Digital Clock Drawing Test: The Framingham Heart Study.

Piers RJ, Devlin KN, Ning B, Liu Y, Wasserman B, Massaro JM, Lamar M, Price CC, Swenson R, Davis R, Penney DL, Au R, Libon DJ.

J Alzheimers Dis. 2017;60(4):1611-1620. doi: 10.3233/JAD-170444.

PMID:
29036819
28.

Association of Multiorgan Computed Tomographic Phenomap With Adverse Cardiovascular Health Outcomes: The Framingham Heart Study.

Shah RV, Yeri AS, Murthy VL, Massaro JM, D'Agostino R Sr, Freedman JE, Long MT, Fox CS, Das S, Benjamin EJ, Vasan RS, O'Donnell CJ, Hoffmann U.

JAMA Cardiol. 2017 Nov 1;2(11):1236-1246. doi: 10.1001/jamacardio.2017.3145.

29.

Effect of a Game-Based Intervention Designed to Enhance Social Incentives to Increase Physical Activity Among Families: The BE FIT Randomized Clinical Trial.

Patel MS, Benjamin EJ, Volpp KG, Fox CS, Small DS, Massaro JM, Lee JJ, Hilbert V, Valentino M, Taylor DH, Manders ES, Mutalik K, Zhu J, Wang W, Murabito JM.

JAMA Intern Med. 2017 Nov 1;177(11):1586-1593. doi: 10.1001/jamainternmed.2017.3458.

30.

Coronary Artery Calcium Distribution Is an Independent Predictor of Incident Major Coronary Heart Disease Events: Results From the Framingham Heart Study.

Ferencik M, Pencina KM, Liu T, Ghemigian K, Baltrusaitis K, Massaro JM, D'Agostino RB Sr, O'Donnell CJ, Hoffmann U.

Circ Cardiovasc Imaging. 2017 Oct;10(10). pii: e006592. doi: 10.1161/CIRCIMAGING.117.006592.

31.

Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial.

Kandzari DE, Mauri L, Koolen JJ, Massaro JM, Doros G, Garcia-Garcia HM, Bennett J, Roguin A, Gharib EG, Cutlip DE, Waksman R; BIOFLOW V Investigators.

Lancet. 2017 Oct 21;390(10105):1843-1852. doi: 10.1016/S0140-6736(17)32249-3. Epub 2017 Aug 26. Erratum in: Lancet. 2017 Oct 21;390(10105):1832.

PMID:
28851504
32.

Association of Coronary Artery Calcium Score vs Age With Cardiovascular Risk in Older Adults: An Analysis of Pooled Population-Based Studies.

Yano Y, O'Donnell CJ, Kuller L, Kavousi M, Erbel R, Ning H, D'Agostino R, Newman AB, Nasir K, Hofman A, Lehmann N, Dhana K, Blankstein R, Hoffmann U, Möhlenkamp S, Massaro JM, Mahabadi AA, Lima JAC, Ikram MA, Jöckel KH, Franco OH, Liu K, Lloyd-Jones D, Greenland P.

JAMA Cardiol. 2017 Sep 1;2(9):986-994. doi: 10.1001/jamacardio.2017.2498.

33.

Guideline-Based Statin Eligibility, Cancer Events, and Noncardiovascular Mortality in the Framingham Heart Study.

Pursnani A, Massaro JM, D'Agostino RB Sr, O'Donnell CJ, Hoffmann U.

J Clin Oncol. 2017 Sep 1;35(25):2927-2933. doi: 10.1200/JCO.2016.71.3594. Epub 2017 Jul 12.

34.

Association of descending thoracic aortic plaque with brain atrophy and white matter hyperintensities: The Framingham Heart Study.

Aparicio HJ, Petrea RE, Massaro JM, Manning WJ, Oyama-Manabe N, Beiser AS, Kase CS, D'Agostino RB, Wolf PA, Vasan RS, DeCarli C, O'Donnell CJ, Seshadri S.

Atherosclerosis. 2017 Oct;265:305-311. doi: 10.1016/j.atherosclerosis.2017.06.919. Epub 2017 Jun 23.

35.

Extended Duration Dual Antiplatelet Therapy After Coronary Stenting Among Patients With Peripheral Arterial Disease: A Subanalysis of the Dual Antiplatelet Therapy Study.

Secemsky EA, Yeh RW, Kereiakes DJ, Cutlip DE, Steg PG, Massaro JM, Apruzzese PK, Mauri L; Dual Antiplatelet Therapy Study Investigators.

JACC Cardiovasc Interv. 2017 May 8;10(9):942-954. doi: 10.1016/j.jcin.2017.02.013.

36.

Relation of Risk Factors and Abdominal Aortic Calcium to Progression of Coronary Artery Calcium (from the Framingham Heart Study).

Onuma OK, Pencina K, Qazi S, Massaro JM, D'Agostino RB Sr, Chuang ML, Fox CS, Hoffmann U, O'Donnell CJ.

Am J Cardiol. 2017 May 15;119(10):1584-1589. doi: 10.1016/j.amjcard.2017.02.021. Epub 2017 Mar 1.

37.

Evidence on the Validity of a Comprehensive Health Risk Index and Implications for Ambulatory Care and Population Health Management.

Massaro JM, Murabito JM, Au R, Carnahan E, Morgan TS, Murray C, Fisher ES, Nelson EC, Lim SS, DʼAgostino RB Sr.

J Ambul Care Manage. 2017 Oct/Dec;40(4):297-304. doi: 10.1097/JAC.0000000000000177.

38.

Residential proximity to major roads, exposure to fine particulate matter and aortic calcium: the Framingham Heart Study, a cohort study.

Dorans KS, Wilker EH, Li W, Rice MB, Ljungman PL, Schwartz J, Coull BA, Kloog I, Koutrakis P, D'Agostino RB, Massaro JM, Hoffmann U, O'Donnell CJ, Mittleman MA.

BMJ Open. 2017 Mar 16;7(3):e013455. doi: 10.1136/bmjopen-2016-013455.

39.

Short-Term Effects of Tolvaptan in Patients With Acute Heart Failure and Volume Overload.

Konstam MA, Kiernan M, Chandler A, Dhingra R, Mody FV, Eisen H, Haught WH, Wagoner L, Gupta D, Patten R, Gordon P, Korr K, Fileccia R, Pressler SJ, Gregory D, Wedge P, Dowling D, Romeling M, Konstam JM, Massaro JM, Udelson JE; SECRET of CHF Investigators, Coordinators, and Committee Members.

J Am Coll Cardiol. 2017 Mar 21;69(11):1409-1419. doi: 10.1016/j.jacc.2016.12.035.

40.

Mortality Following Cardiovascular and Bleeding Events Occurring Beyond 1 Year After Coronary Stenting: A Secondary Analysis of the Dual Antiplatelet Therapy (DAPT) Study.

Secemsky EA, Yeh RW, Kereiakes DJ, Cutlip DE, Cohen DJ, Steg PG, Cannon CP, Apruzzese PK, D'Agostino RB Sr, Massaro JM, Mauri L; Dual Antiplatelet Therapy (DAPT) Study Investigators.

JAMA Cardiol. 2017 May 1;2(5):478-487. doi: 10.1001/jamacardio.2017.0063.

41.

Upper Body Subcutaneous Fat Is Associated with Cardiometabolic Risk Factors.

Lee JJ, Pedley A, Therkelsen KE, Hoffmann U, Massaro JM, Levy D, Long MT.

Am J Med. 2017 Aug;130(8):958-966.e1. doi: 10.1016/j.amjmed.2017.01.044. Epub 2017 Feb 24.

42.

Myocardial Infarction Risk After Discontinuation of Thienopyridine Therapy in the Randomized DAPT Study (Dual Antiplatelet Therapy).

Stefanescu Schmidt AC, Kereiakes DJ, Cutlip DE, Yeh RW, D'Agostino RB Sr, Massaro JM, Hsieh WH, Mauri L; DAPT Investigators.

Circulation. 2017 May 2;135(18):1720-1732. doi: 10.1161/CIRCULATIONAHA.116.024835. Epub 2017 Feb 22.

43.

Relation of Iliac Artery Calcium With Adiposity Measures and Peripheral Artery Disease.

Lee JJ, Pedley A, Weinberg I, Britton KA, Massaro JM, Hoffmann U, Manders E, Fox CS, Murabito JM.

Am J Cardiol. 2017 Apr 15;119(8):1217-1223. doi: 10.1016/j.amjcard.2016.12.037. Epub 2017 Jan 25.

44.

Greater remnant lipoprotein cholesterol reduction with pitavastatin compared with pravastatin in HIV-infected patients.

Joshi PH, Miller PE, Martin SS, Jones SR, Massaro JM, D'Agostino RB Sr, Kulkarni KR, Sponseller C, Toth PP.

AIDS. 2017 Apr 24;31(7):965-971. doi: 10.1097/QAD.0000000000001423.

PMID:
28121706
45.

Incident Type 2 Myocardial Infarction in a Cohort of Patients Undergoing Coronary or Peripheral Arterial Angiography.

Gaggin HK, Liu Y, Lyass A, van Kimmenade RR, Motiwala SR, Kelly NP, Mallick A, Gandhi PU, Ibrahim NE, Simon ML, Bhardwaj A, Belcher AM, Harisiades JE, Massaro JM, D'Agostino RB Sr, Januzzi JL Jr.

Circulation. 2017 Jan 10;135(2):116-127. doi: 10.1161/CIRCULATIONAHA.116.023052. Epub 2016 Nov 21.

PMID:
27881568
46.

Prevalence and Prognostic Implications of Coronary Artery Calcification in Low-Risk Women: A Meta-analysis.

Kavousi M, Desai CS, Ayers C, Blumenthal RS, Budoff MJ, Mahabadi AA, Ikram MA, van der Lugt A, Hofman A, Erbel R, Khera A, Geisel MH, Jöckel KH, Lehmann N, Hoffmann U, O'Donnell CJ, Massaro JM, Liu K, Möhlenkamp S, Ning H, Franco OH, Greenland P.

JAMA. 2016 Nov 22;316(20):2126-2134. doi: 10.1001/jama.2016.17020.

PMID:
27846641
47.

Design and Rationale of the RE-DUAL PCI Trial: A Prospective, Randomized, Phase 3b Study Comparing the Safety and Efficacy of Dual Antithrombotic Therapy With Dabigatran Etexilate Versus Warfarin Triple Therapy in Patients With Nonvalvular Atrial Fibrillation Who Have Undergone Percutaneous Coronary Intervention With Stenting.

Cannon CP, Gropper S, Bhatt DL, Ellis SG, Kimura T, Lip GY, Steg PG, Ten Berg JM, Manassie J, Kreuzer J, Blatchford J, Massaro JM, Brueckmann M, Ferreiros Ripoll E, Oldgren J, Hohnloser SH; RE-DUAL PCI Steering Committee and Investigators.

Clin Cardiol. 2016 Oct;39(10):555-564. doi: 10.1002/clc.22572. Epub 2016 Aug 26.

48.

Bi-directional analysis between fatty liver and cardiovascular disease risk factors.

Ma J, Hwang SJ, Pedley A, Massaro JM, Hoffmann U, Chung RT, Benjamin EJ, Levy D, Fox CS, Long MT.

J Hepatol. 2017 Feb;66(2):390-397. doi: 10.1016/j.jhep.2016.09.022. Epub 2016 Oct 10.

49.

Association of Changes in Abdominal Fat Quantity and Quality With Incident Cardiovascular Disease Risk Factors.

Lee JJ, Pedley A, Hoffmann U, Massaro JM, Fox CS.

J Am Coll Cardiol. 2016 Oct 4;68(14):1509-21. doi: 10.1016/j.jacc.2016.06.067.

50.

Lung Cancer Screening Eligibility in the Community: Cardiovascular Risk Factors, Coronary Artery Calcification, and Cardiovascular Events.

Lu MT, Onuma OK, Massaro JM, D'Agostino RB Sr, O'Donnell CJ, Hoffmann U.

Circulation. 2016 Sep 20;134(12):897-9. doi: 10.1161/CIRCULATIONAHA.116.023957. No abstract available.

Supplemental Content

Loading ...
Support Center